13F-HR filed by ORBIMED ADVISORS LLC
ORBIMED ADVISORS LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:17:43 UTC, with 124 holding rows worth $5,498,486,689.
- Accession
- 0001172661-26-005349
- Filer
- CIK 1055951
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
13F report for Q3 2026
A holdings report, 124 entries on the cover page, a total value of $5,498,486,689 stated on the cover page (in dollars after the unit check, H1), rows summing to $5,498,486,689 with VALUE read as dollars as filed, 13F file number 028-06774. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerORBIMED CAPITAL LLC028-10410
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 15,518,492 | $630,050,775 | dollars as filed | |
| ADARx Pharmaceuticals, Inc. | 00654F105 | Common Stock, par value $0.0001 per share | 24,205,789 | $482,663,433 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 6,776,632 | $310,640,811 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 257,900 | $298,410,932 | dollars as filed | |
| Braveheart Bio Inc | 10567X101 | COM | 12,175,159 | $245,938,212 | dollars as filed | |
| SINOVAC BIOTECH LTD | P8696W104 | SHS | 2,718,735 | $195,500,000 | dollars as filed | |
| MBX BIOSCIENCES INC COM | 55287L101 | Stock | 3,074,853 | $180,247,883 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 946,100 | $137,477,791 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 584,100 | $104,180,076 | dollars as filed | |
| ARRIVENT BIOPHARMA INC | 04272N102 | COM | 3,027,328 | $91,667,492 | dollars as filed | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 7,165,006 | $82,540,869 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 199,700 | $82,538,007 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 3,122,100 | $82,517,103 | dollars as filed | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 120,400 | $81,276,020 | dollars as filed | |
| UnitedHealth Group Inc | 91324P102 | COM | 219,000 | $80,390,520 | dollars as filed | |
| ASCENDIS PHARMA A/S | K08588103 | ORD SHS *A* | 345,200 | $78,646,916 | dollars as filed | |
| Electra Therapeutics, Inc. | 284825106 | Common Stock, $0.0001 par value per share | 6,885,170 | $77,458,163 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 75,180 | $72,090,854 | dollars as filed | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 834,900 | $72,068,568 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 1,200,425 | $70,681,024 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 2,777,621 | $69,301,644 | dollars as filed | |
| AbbVie,Inc. | 00287Y109 | COM | 259,600 | $67,908,764 | dollars as filed | |
| CARIS LIFE SCIENCES INC | 142152107 | COMMON STOCK | 2,192,911 | $67,168,864 | dollars as filed | |
| Odyssey Therapeutics, Inc. | 67613T104 | COMMON STOCK | 3,001,198 | $66,686,620 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 2,003,700 | $64,158,474 | dollars as filed | |
| ASTRAZENECA PLC ORD | G0593M107 | ADR | 379,300 | $61,782,783 | dollars as filed | |
| CAREDX INC | 14167L103 | COM | 934,800 | $60,762,000 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 200,400 | $58,362,492 | dollars as filed | |
| Abbott Laboratories | 002824100 | COM | 579,000 | $57,222,570 | dollars as filed | |
| PRELUDE THERAPEUTICS INC | 74065P101 | CMN | 13,724,571 | $53,663,073 | dollars as filed | |
| BLOSSOMHILL THERAPEUTICS INC | 095130100 | COM | 2,714,279 | $50,594,161 | dollars as filed | |
| HUMANA INC COM | 444859102 | Stock | 127,800 | $48,764,646 | dollars as filed | |
| SHATTUCK LABS INC | 82024L103 | COMMON STOCK | 6,306,127 | $43,007,786 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 1,331,000 | $41,620,370 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 988,487 | $40,162,227 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 96,800 | $39,361,784 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 408,000 | $38,847,720 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 1,454,572 | $36,553,394 | dollars as filed | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 8,288,510 | $35,723,478 | dollars as filed | |
| Q32 BIO INC | 746964105 | Common Stock | 4,127,987 | $34,138,452 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 97,700 | $32,491,112 | dollars as filed | |
| PALVELLA THERAPEUTICS INC | 697947109 | COMMON STOCK | 229,860 | $31,704,590 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 170,878 | $31,508,194 | dollars as filed | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 131,100 | $30,352,272 | dollars as filed | |
| UPSTREAM BIO INC | 91678A107 | COMMON STOCK | 5,693,589 | $30,005,214 | dollars as filed | |
| WEST PHARMACEUTICAL SVSC INC COM | 955306105 | Stock | 80,180 | $29,727,537 | dollars as filed | |
| Latigo Biotherapeutics, Inc. | 517954103 | Common Stock, par value $0.0001 per share | 1,675,316 | $27,977,777 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 314,500 | $25,009,040 | dollars as filed | |
| SCRIBE THERAPEUTIC COM | 811033109 | COM | 1,348,825 | $24,825,124 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 278,000 | $23,988,620 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 384,520 | $23,280,763 | dollars as filed | |
| 0 | 000000000 | 0 | 5,680,186 | $22,209,527 | dollars as filed | |
| VOGENX INC | 92859A106 | COM | 968,621 | $22,074,873 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 150,000 | $21,133,500 | dollars as filed | call |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 1,555,900 | $20,957,973 | dollars as filed | |
| AURA BIOSCIENCES INC | 05153U107 | COMMON STOCK | 3,333,333 | $20,933,331 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 3,959,900 | $20,433,084 | dollars as filed | |
| APNIMED INC | 03770Y107 | COM | 925,000 | $20,266,750 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 811,000 | $19,593,760 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 2,230,939 | $19,587,644 | dollars as filed | |
| PYXIS ONCOLOGY INC COMMON STOCK | 747324101 | Stock | 8,361,917 | $19,483,267 | dollars as filed | |
| ACHIEVE LIFE SCIENCES INC | 004468500 | COMMON STOCK | 2,344,200 | $18,964,578 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 185,022 | $18,320,878 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 79,400 | $17,934,872 | dollars as filed | |
| KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A | G52694109 | Stock | 238,900 | $17,824,329 | dollars as filed | |
| WATERS CORP COM | 941848103 | Stock | 40,300 | $17,707,417 | dollars as filed | |
| DEFINIUM THERAPEUTICS INC | 24477V105 | COM SHS | 443,900 | $16,894,834 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 505,000 | $16,367,050 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 15,219,994 | $15,828,794 | dollars as filed | |
| CVS Health Corporation | 126650100 | COM | 182,600 | $15,646,994 | dollars as filed | |
| NEUROPACE INC | 641288105 | COMMON STOCK | 1,055,125 | $14,518,520 | dollars as filed | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 3,853,472 | $14,489,055 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 70,500 | $14,470,830 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 965,300 | $13,823,096 | dollars as filed | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 26,200 | $13,697,622 | dollars as filed | |
| SIONNA THERAPEUTICS INC | 829401108 | COMMON STOCK | 2,469,959 | $12,991,984 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 194,300 | $12,716,935 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 1,506,000 | $12,544,980 | dollars as filed | |
| SUTRO BIOPHARMA INC | 869367201 | COMMON STOCK | 743,944 | $11,984,938 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 806,000 | $11,815,960 | dollars as filed | |
| SPRUCE BIOSCIENCES INC | 85209E208 | COM NEW | 242,800 | $11,795,224 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 1,665,656 | $11,359,774 | dollars as filed | |
| LEXEO THERAPEUTICS INC | 52886X107 | COMMON STOCK | 3,203,050 | $10,826,309 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 100,000 | $9,902,000 | dollars as filed | call |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 2,000,000 | $9,740,000 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 524,700 | $9,066,816 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 759,155 | $8,654,367 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 1,670,079 | $6,296,198 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 30,000 | $6,157,800 | dollars as filed | call |
| ADICET BIO INC | 007002207 | COM NEW | 844,787 | $6,031,779 | dollars as filed | |
| Yarrow Bioscience, Inc. | 92941V407 | Common Stock, $0.0001 par value | 266,306 | $5,997,211 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422GAB3 | NOTE 0.500% 5/1 | 5,000,000 | $5,944,700 | dollars as filed | principal |
| XILIO THERAPEUTICS INC | 98422T209 | COM | 592,300 | $5,360,315 | dollars as filed | |
| BIOAGE LABS INC COM | 09077V100 | Stock | 711,811 | $5,046,740 | dollars as filed | |
| REVOLUTION MEDICINES INC | 76155XAA8 | NOTE 0.500% 5/0 | 3,500,000 | $4,516,435 | dollars as filed | principal |
| IMMUNIC INC | 4525EP200 | COM NEW | 475,804 | $4,424,977 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 47,326 | $4,213,434 | dollars as filed | |
| IMAGENEBIO INC | 45175G207 | CMN | 909,269 | $4,164,452 | dollars as filed | |
| Danaher Corporation | 235851102 | COM | 18,600 | $4,120,830 | dollars as filed | |
| ALUMIS INC | 022307102 | COM | 548,163 | $4,050,925 | dollars as filed | |
| BRIGHT MINDS BIOSCIENCES INC | 10919W405 | COMMON STOCK | 81,000 | $4,035,420 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 8,000 | $4,031,680 | dollars as filed | |
| ARTIVION INC | 228903100 | COM | 175,000 | $3,993,500 | dollars as filed | |
| TECTONIC THERAPEUTIC INC | 878972108 | COMMON STOCK | 166,102 | $3,868,516 | dollars as filed | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 2,742,968 | $3,812,726 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 150,000 | $3,742,500 | dollars as filed | call |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 42,300 | $3,724,515 | dollars as filed | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 1,315,355 | $3,643,533 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 54,300 | $3,258,000 | dollars as filed | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 49,100 | $3,180,698 | dollars as filed | |
| BRUKER CORP | 116794108 | COM | 48,400 | $3,133,900 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 34,600 | $2,719,906 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 739,691 | $2,418,790 | dollars as filed | |
| BELITE BIO INC | 07782B104 | CMN | 13,300 | $2,258,606 | dollars as filed | |
| INSPIREMD INC | 45779A846 | COM | 3,133,405 | $2,092,488 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 250,000 | $2,082,500 | dollars as filed | call |
| UNICYCIVE THERAPEUTICS INC | 90466Y202 | COMMON STOCK | 387,000 | $1,816,965 | dollars as filed | |
| EUPRAXIA PHARMACEUTICALS INC | 29842P105 | COM 298736 AL 3 EURONET WORLDWIDE INC NOTE 0.750% 3/1 | 194,720 | $1,771,952 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 220,000 | $1,687,400 | dollars as filed | |
| EVOMMUNE INC | 30054Y107 | COMMON STOCK | 161,000 | $1,329,860 | dollars as filed | |
| GINKGO BIOWORKS HOLDINGS INC | 37611X209 | COMMON STOCK | 100,000 | $1,283,000 | dollars as filed | call |
| SELLAS LIFE SCIENCES GROUP I | 81642T209 | COM NEW | 100,000 | $1,231,000 | dollars as filed | put |
| TRAWS PHARMA INC | 68232V884 | COM NEW | 1,203,260 | $714,496 | dollars as filed | |
| MDXHEALTH SA | B5950S113 | SHS NEW | 1,243,060 | $120,083 | dollars as filed | call |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-26-005349 | this filing | 2026-11-16 |